DRG-Blog » Kardiologie

Improved Cardiac Management with a Disease Management Program Incorporating Comprehensive Lipid Profiling

Jannis — Mon, 19 Dec 2011 12:12:34 +0000

John F. McAna, Neil I. Goldfarb, Joseph Couto, Michelle A. Henry, Gary Piefer, and George M. Rapier III:
Improved Cardiac Management with a Disease Management Program Incorporating Comprehensive Lipid Profiling
Population Health Management., ahead of print. Mary Ann Liebert, Inc., publishers

[DOI: 10.1089/pop.2011.0024]

Comparison of Hospitalization Costs and Medicare Payments for Carotid Endarterectomy and Carotid Stenting in Asymptomatic Patients

Jannis — Tue, 29 Nov 2011 14:55:38 +0000

R.J. McDonald, D.F. Kallmes, and H. J. Cloft:
Comparison of Hospitalization Costs and Medicare Payments for Carotid Endarterectomy and Carotid Stenting in Asymptomatic Patients
AJNR Am J Neuroradiol 2011 originally published online on November 24, 2011, American Society of Neuroradiology

[DOI: 10.3174/ajnr.A2791]

Cost-Effectiveness Analysis of Continuous Flow Left Ventricular Assist Devices as Destination Therapy

Jannis — Fri, 11 Nov 2011 08:42:02 +0000

Joseph G. Rogers, Robin R. Bostic, Kuo B. Tong, Rob Adamson, Mark Russo and Mark S. Slaughter:
Cost-Effectiveness Analysis of Continuous Flow Left Ventricular Assist Devices as Destination Therapy
Circ Heart Fail. 2011;published online before print November 3 2011, American Heart Association

[DOI: 10.1161/CIRCHEARTFAILURE.111.962951]

Resource use and costs in systolic heart failure according to disease severity: a pooled analysis from the German Competence Network Heart Failure

Jannis — Mon, 07 Nov 2011 11:33:01 +0000

Janine Biermann, Till Neumann, Christiane E. Angermann, Hans-Dirk Düngen, Raimund Erbel, Wolfgang Herzog, Bernhard Maisch, Thomas Müller-Tasch, Cemil Özcelik und Sabine Pankuweit, et al:
Resource use and costs in systolic heart failure according to disease severity: a pooled analysis from the German Competence Network Heart Failure
Journal of Public Health, Online First, Springer Verlag

[DOI: 10.1007/s10389-011-0452-0]

Cost-effectiveness analysis: cardiovascular benefits of proton pump inhibitor co-therapy in patients using aspirin for secondary prevention

Jannis — Wed, 22 Jun 2011 07:44:27 +0000

S. D. Saini, A. M. Fendrick, J. M. Scheiman:
Cost-effectiveness analysis: cardiovascular benefits of proton pump inhibitor co-therapy in patients using aspirin for secondary prevention
Alimentary Pharmacology & Therapeutics, Volume 34, Issue 2, pages 243–251, July 2011, Blackwell Publishing

[DOI: 10.1111/j.1365-2036.2011.04707.x]

Medikamentenfreisetzende Stents der 2. Generation – Neu, aber auch kosteneffektiv?

Jannis — Mon, 20 Jun 2011 06:59:12 +0000

F. Müller-Riemenschneider, T. Reinhold and S.N. Willich:
Medikamentenfreisetzende Stents der 2. Generation – Neu, aber auch kosteneffektiv?
Second-generation DES – New, but also cost-effective?
Herz, Volume 36, Number 3, 254-261, Urban & Vogel, Muenchen

[DOI: 10.1007/s00059-011-3463-2]

Ultrafiltration for Acute Decompensated Heart Failure: Cost, Reimbursement, and Financial Impact

Jannis — Tue, 17 May 2011 07:37:27 +0000

Edward A. Ross MD, Frank B. Bellamy RN, MSN, Scott Hawig CPA, CMA, Amir Kazory MD:
Ultrafiltration for Acute Decompensated Heart Failure: Cost, Reimbursement, and Financial Impact
Clinical Cardiology, Volume 34, Issue 5, pages 273–277, May 2011, John Wiley & Sons

[DOI: 10.1002/clc.20913]

Congenital heart disease: interrelation between German diagnoses-related groups system and Aristotle complexity score

Jannis — Thu, 14 Apr 2011 12:13:12 +0000

William Galbraith Williams:
Congenital heart disease: interrelation between German diagnoses-related groups system and Aristotle complexity score
European Journal of Cardio-Thoracic Surgery, Editorial comment, Volume 37, Issue 6, June 2010, Pages 1276-1277

[DOI: 10.1016/j.ejcts.2010.02.041]

Cost-Effectiveness of Rosuvastatin for Primary Prevention of Cardiovascular Events According to Framingham Risk Score in Patients With Elevated C-Reactive Protein

Jannis — Tue, 15 Mar 2011 15:50:44 +0000

Gary P. MacDonald, DO, MS:
Cost-Effectiveness of Rosuvastatin for Primary Prevention of Cardiovascular Events According to Framingham Risk Score in Patients With Elevated C-Reactive Protein
JAOA, Vol 110, No 8, August 2010, 427-436, American Osteopathic Association

[JAOA]

Kodierung: Koronarstents

Jannis — Thu, 10 Feb 2011 08:12:08 +0000

Die Seite der DE-Stents wurde für die OPS Version 2011 aktualisiert und für alle Koronarstents angepaßt.

[Kodierung: Koronarstents]